tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Bailey, 9 are a BUY (75%), 3 are a HOLD (25%).
Analyst David Bailey, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 66.67% that have a potential upside of 26.45% achieved within 136 days. Previously, David Bailey worked at MACQUARIE.
David Bailey’s has documented 17 price targets and ratings displayed on 3 stocks. The coverage is on Healthcare, Consumer Cyclical, Industrials sectors.
Most recent stock forecast was given on RMD, ResMed at 17-Jun-2026.
Analyst best performing recommendations are on CSL (CARLISLE COMPANIES).
The best stock recommendation documented was for RMD (RESMED) at 6/17/2026. The price target of $230 was fulfilled within 63 days with a profit of $43.71 (23.46%) receiving and performance score of 3.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Oct-2025
$215
$-16.52 (-7.14%)
$225
Buy Since 06-Feb-2024
$255
$23.48 (10.14%)
$290
Hold Since 07-Aug-2026
$244
$12.48 (5.39%)
$234
Hold Since 10-Jan-2025
$225
$-6.52 (-2.82%)
$275
Buy Since 14-Apr-2023
$220
$-11.52 (-4.98%)
$300
Which stock is David Bailey is most bullish on?
What Year was the first public recommendation made by David Bailey?
